Richard James Glassock, M.D.
NPI 1649548579ActiveIndividual· Internal Medicine, Nephrology· Laguna Niguel, CA
Internal Medicine, Nephrology (M.D.) in Laguna Niguel, California, licensed in CA, with an NPI issued in December 2011. Novartis Pharmaceuticals Corporation was the largest of 14 companies reporting payments in 2025, $31,786 in all, mostly consulting fees.
Overview
| NPI | 1649548579 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Dec 7, 2011 |
| Last updated in NPPES | Dec 7, 2011 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Nephrology Primary | 207RN0300X | A19764 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Industry payments (Open Payments)
- 2025$31,786 · 49 payments from 14 companies
- 2024$35,716 · 46 payments from 11 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novartis Pharmaceuticals Corporation | $10,046 | 17 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $9,161 | 3 |
| F. Hoffmann-La Roche Ag | $6,588 | 4 |
| Genentech, Inc. | $2,135 | 1 |
| Alexion Pharmaceuticals, Inc. | $1,500 | 3 |
What the 2025 payments were for
- Consulting Fee$25,836 · 8 payments
- Travel and Lodging$3,518 · 9 payments
- Food and Beverage$2,431 · 32 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records